Migration of BioWorld Science to complete BioWorld brand
LONDON, Sept. 15,
2022 /PRNewswire/ -- BioWorld published
by Clarivate Plc (NYSE:CLVT), a global leader in
providing trusted information and insights to accelerate the pace
of innovation, today announced BioWorld Science will transition
entirely to bioworld.com for an improved experience and expanded
news offering. The migration will mark the completion of the
BioWorld brand consolidation, which combined news solutions across
the BioWorld portfolio into one seamless and integrated platform.
As part of the move to bioworld.com, BioWorld Science readers
can now access in-depth coverage of top news, plus more short-form
articles for easy scanning. In addition, new enhancements, such as
intuitive navigation and increased content, will increase the value
of this news service.
BioWorld Science delivers discovery and preclinical research
news to support crucial drug R&D decisions at the earliest
stages every business day. The industry-leading coverage of
research news has enabled access to the latest breakthroughs in
discovery and preclinical news, including exclusive coverage of
hormones that improve cognitive function in Down syndrome and
researchers creating mid-gestation embryos from stem cells.
Scan headlines from all BioWorld news services
- With news solutions combined on one Clarivate platform,
customers can see headlines and summaries from the flagship news
service, BioWorld, as well as BioWorld MedTech and BioWorld Asia.
Additionally, customers will have free access to special reports
and 7,000+ COVID-19 articles and data.
Harmonized coverage, data and insights
- Readers will be exposed to the full spectrum of BioWorld news.
In addition, subscribers will have access to links from BioWorld to
Cortellis Drug Discovery Intelligence™ to support customer movement
from news to deeper dives into data and insights.
- In addition to the familiar chemical structure images published
in BioWorld Science for many years, bioworld.com includes
infographics illustrating industry trends as well as free access to
podcasts via the BioWorld Insider Podcast.
- The new site will include major topical sections that can be
bookmarked for direct linking to read updates.
Access content when and where you need it most
- Each day, subscribers will receive a new e-newsletter for easy
access to read today's news. The newsletter will feature the day's
article headlines and summaries linked to the site.
- Building on BioWorld's social media presence on Twitter, the
new handle, @BioWorldScience, will be introduced. Readers are
encouraged to follow and join the conversation with
- The BioWorld brand consolidation also includes a new
mobile-friendly platform featuring content from across BioWorld
Lynn Yoffee, Publisher,
BioWorld said: "BioWorld has always covered the complete
lifecycle of innovation in drug development. With the addition and
expansion of BioWorld Science, we have a news service that will
highlight the most astonishing stories with exclusive, one-on-one
interviews with researchers. The pace and volume of scientific
research accelerated so much that keeping up with the most
important industry news can be challenging. BioWorld Science is the
solution for those who must stay on top of the most impactful
research and news related to human therapeutics."
For more on the migration of BioWorld Science to bioworld.com,
With writers and editors stationed
around the globe, BioWorld published by Clarivate,
reports the breaking news - and provides key perspective on
hundreds of therapeutics and devices in development, the companies
behind those candidates, the business development transactions that
evolve the markets, and the regulatory hurdles that both challenge
and guard the processes. BioWorld has a long tradition of
excellence in journalism. Collectively, the news services have been
honored with 63 awards dating back to 1998, including 15 for
BioWorld daily news services.
Clarivate™ is a global leader in providing solutions to accelerate
the pace of innovation. Our bold mission is to help customers solve
some of the world's most complex problems by providing actionable
information and insights that reduce the time from new ideas to
life-changing inventions in the areas of Academia & Government,
Life Sciences & Healthcare, Professional Services and Consumer
Goods, Manufacturing & Technology. We help customers discover,
protect and commercialize their inventions using our trusted
subscription and technology-based solutions coupled with deep
domain expertise. For more information, please
Director, External Communications, Life Sciences &
View original content to download
SOURCE Clarivate Plc